---
granola_id: 9e2c2b5c-1293-42e1-9f69-ab965bd975c0
title: "Catch-up Call with Virtue and Bessemer"
type: note
created: 2025-10-15T12:12:27.776Z
updated: 2025-10-15T12:46:56.503Z
attendees:
  - Morgan Cheatham
  - Sean Doolan
  - Sofia Guerra
---
### Investment Portfolio Updates

- Translucent raised $105M post-money (down from $150M verbals)
	- Deal expected to wire within a month
- Guide (rollup, Will Johnson) signed $50M Series A terms with Lightspeed
	- 15-20M chunk still needs filling
	- Earlier than expected by 30-40 days
	- Currently at 70+ revenue, 5-6M EBITDA
- Prudential term sheet expected any day
	- Series A, $20-25M range
	- GV did seed, Sofika catalyzed recent activity
- Integral likely raising Series A in November (originally planned January)
	- TCAP showing strong interest
	- Growth from 0-2.6M over 9 months
	- Expecting 0-9M with upcoming contracts
	- Founder (Shub) injured, homebound in New York

### Recent New Investments

- Standard Model Bio
	- Not drug discovery - builds foundation models for rest of pharma value chain
	- Predicting PTRs, clinical trial design, biomarker stratification
	- Large ACVs with big pharma, partners with AMCs/biobanks for data
	- Potential Series A Q1 with JP Morgan leading process
	- Team of 7 technical experts building multimodal foundation models
- Dart Health (22-year-old founder)
	- AI deployment platform for health systems (Palantir/Percepta-esque)
	- Hit $1M run rate, 80% acquired in prior 60 days
	- Expected to double in next 60 days
	- 80-85% gross margins, profitable
	- 100+ use cases, competing head-to-head with Beryllium
	- Duke-based founder, announcing tomorrow

### Market Dynamics & Valuations

- Tandem valuation discussion: 7-800M (up from 200M)
	- Revenue model questioned - script-based, not recurring
	- Only 25% physician adoption, contracted vs actual revenue unclear
- Slingshot at $450M valuation
	- Forerunner invested after one meeting, no data room access
	- Company facing heat over claims, still figuring out identity
- Consumer health AI skepticism
	- Mentla pivoted to AI therapy, raised $10M in under a week
	- Concerns about clinical protocols and legal liability
- OpenAI health challenges: 8-12% of prompts health-related
	- Suicidal ideation major priority/risk
	- Similar compliance fears as Google

### Resources & Follow-ups

- Engineering platform details: https://engineering.zingage.com/how-we-built-a-data-platform-for-ai-agents/
- Solstice progressing well - direct pharma sales vs agencies
	- Zero to 1M+ ARR in 40 days
	- MLR contracts larger/faster than expected

Chat with meeting transcript: https://notes.granola.ai/d/9e2c2b5c-1293-42e1-9f69-ab965bd975c0
